Target intelligence / Profile preview

Mycobacterium tuberculosis antigens presented by Major Histocompatibility Complex (Mtb-pMHC)

Target
Mtb-pMHC
Molecular classification
Antigen, Peptide-MHC complex, Other
01

Overview

Mycobacterium tuberculosis (Mtb) antigens presented by the Major Histocompatibility Complex (MHC) are the primary targets for cellular immune recognition during tuberculosis infection. These targets are not individual proteins in the traditional sense but are peptide fragments derived from Mtb proteins—such as ESAT-6, CFP-10, and the Antigen 85 complex—that are processed and displayed on the surface of infected macrophages via MHC Class I and Class II molecules (Flynn & Chan, 2001; Sorensen et al., 1995). The recognition of these peptide-MHC (pMHC) complexes by T-cell receptors (TCRs) is fundamental to the host's ability to mount a protective immune response, involving the secretion of pro-inflammatory cytokines like interferon-gamma (IFN-γ) and the direct lysis of infected cells (Jasenosky et al., 2015). In clinical practice, these immunological targets are exploited for both diagnostics and vaccine development. Vaccines like BCG and newer candidates such as M72/AS01E aim to prime the immune system to recognize these specific antigens more effectively upon exposure to Mtb (Tait et al., 2019). However, the high degree of polymorphism in human HLA genes and the ability of Mtb to evade immune detection by modulating antigen presentation present significant therapeutic challenges. Furthermore, excessive immune activation against these targets can lead to tissue damage or the Koch phenomenon, a severe inflammatory response in individuals with pre-existing sensitivity to Mtb antigens (Andersen, 2007).

Other names
Mycobacterium tuberculosis antigensMtb T-cell epitopesMtb peptide-MHC complexesMtb pMHCTuberculosis antigens
02

Mechanism of action

Induction of antigen-specific T-cell mediated immunity through the recognition of Mycobacterium tuberculosis-derived peptides (e.g., ESAT-6, CFP-10, Ag85B) presented on host MHC Class I and Class II molecules by T-cell receptors (TCRs), leading to cytokine production and macrophage activation (Flynn & Chan, 2001; Jasenosky et al., 2015).

03

Biological functions

Immune responseAntigen presentationT-cell activationCellular immunity
04

Disease associations

Infection
05

Safety considerations

Koch phenomenon (severe necrotic inflammatory response)Immune-mediated tissue damageVariable efficacy due to HLA polymorphismPotential for cross-reactivity with self-antigensCytokine release syndrome (theoretical in high-potency immunotherapies)
06

Interacting drugs

Bacillus Calmette-Guerin (BCG) vaccine

6 more in the full profile.

07

Biomarkers

Interferon-gamma (IFN-g)Tumor Necrosis Factor-alpha (TNF-a)Interleukin-2 (IL-2)Antigen-specific CD4+ T-cell frequencyAntigen-specific CD8+ T-cell frequency

Beyond the preview

Go deeper on Mycobacterium tuberculosis antigens presented by Major Histocompatibility Complex (Mtb-pMHC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis antigens presented by Major Histocompatibility Complex (Mtb-pMHC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call